TNFRSF11A and breast cancer: Patients with RANK+ tumors tended to have a poorer distant metastasis‐free survival (DMFS) (IDB and NPS) and BC‐specific survival (BCSS) (NPS) compared with those with RANK− tumors (Fig 1D; Dataset EV1).